• Home
  • News
  • Portfolio News
  • Corbus Pharmaceuticals receives Orphan Designation for lenabasum for the treatment of DM in EU

Corbus Pharmaceuticals receives Orphan Designation for lenabasum for the treatment of DM in EU

19Sep

Corbus Pharmaceuticals receives Orphan Designation for lenabasum for the treatment of DM in EU

Portfolio News

Corbus Pharmaceuticals announces that the European Commission has granted Orphan Designation in the European Union (EU) to lenabasum, its synthetic oral endocannabinoid-mimetic drug, for the treatment of dermatomyositis (DM). Read more >>

Share this post

Related Posts

20May

Zylö and Amifar Laboratorios Forge Broad-Ranging Partnership

Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced that it has entered into a broad-ranging agreement... read more
08Jun

Myomo scales up production, training for MyoPro device for upper-body mobility

From perception and analysis to actuation, many robotics technologies have applications in healthcare, particularly in prosthetics and assistive systems. Myomo... read more
05Dec

Winter Innovations Secures $1 Million NSF Grant to Advance Innovative Orthopedic Suturing Device

Winter Innovations Inc. is thrilled to announce that the company has been awarded a $1,000,000 Phase II Small Business Innovation... read more
20Oct

Meet The New Unicorns Minted In September 2022

Twelve companies joined The Crunchbase Unicorn Board in September 2022, adding $19.6 billion in value to the board. These companies have... read more
04Oct

Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual Meeting

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, announced the presentation... read more
25Sep

Startups, be ready. Epicenter and SOE’s $10K pitch competition, The Next Big Thing, is back

In year one, Phillip Ashley Rix and his company, Phillip Ashley Chocolates, claimed victory. In year two, Lia Winter and... read more
27Oct

Judges pick 10 finalists for Buffalo’s 43North contest from strong field of startups

For several tense moments Wednesday afternoon, the founders of 15 startups stood along one side of the Atrium @ Rich’s... read more
14Jun

Corbus Pharmaceuticals Presents 1-Year Systemic Sclerosis and 6-Month Dermatomyositis Data from Open-Label Extension of Phase 2 Lenabasum Studies at EULAR 2018

Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to... read more
01May

VSTECS Singapore partners with Wasabi in cloud storage play

Wasabi Techologies has partnered with VSTECS Singapore to distribute Wasabi’s predictable, high-performance cloud storage solutions in the market. “As Asia’s... read more
05May

How to size up a new cloud service like low-priced Wasabi

Saving money may be a good enough reason to try a brand-new cloud storage service -- if it can deliver... read more